Patients treated for mental illness face more barriers to drug approval and access, study finds
OTTAWA – A new study finds that patients treated for mental illness in Canada are waiting far too long to get drug approval and face inequitable access across the country. The Mood Disorders Society of Canada’s study, System Broken, finds that Canadians who rely on public drug plans are at a particular disadvantage. As we …
